BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34157757)

  • 1. [Treatment of eosinophilic esophagitis - advancements and perspectives].
    Miehlke S; von Arnim U; Schlag C; Labenz J; Madisch A
    Z Gastroenterol; 2021 Aug; 59(8):869-878. PubMed ID: 34157757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of eosinophilic esophagitis - advancements and perspectives].
    Miehlke S; Arnim UV; Schlag C; Labenz J; Madisch A
    Laryngorhinootologie; 2023 May; 102(5):339-348. PubMed ID: 37141876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of eosinophlic esophagitis with swallowed topical corticosteroids.
    Nennstiel S; Schlag C
    World J Gastroenterol; 2020 Sep; 26(36):5395-5407. PubMed ID: 33024392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence.
    Miehlke S; Lucendo AJ; Straumann A; Jan Bredenoord A; Attwood S
    Therap Adv Gastroenterol; 2020; 13():1756284820927282. PubMed ID: 32565912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real-world efficacy from the EoE CONNECT registry.
    Laserna-Mendieta EJ; Navarro P; Casabona-Francés S; Savarino EV; Amorena E; Pérez-Martínez I; Guagnozzi D; Blas-Jhon L; Betoré E; Guardiola-Arévalo A; Pellegatta G; Krarup AL; Perello A; Barrio J; Gutiérrez-Junquera C; Teruel Sánchez-Vegazo C; Fernández-Fernández S; Naves JE; Oliva S; Rodríguez-Oballe JA; Carrión S; Espina S; Llorente Barrio M; Masiques-Mas ML; Dainese R; Feo-Ortega S; Martín-Dominguez V; Fernández-Pacheco J; Pérez-Fernández MT; Ghisa M; Maniero D; Nantes-Castillejo Ó; Nicolay-Maneru J; Suárez A; Maray I; Llerena-Castro R; Ortega-Larrodé A; Alcedo J; Granja Navacerrada A; Racca F; Santander C; Arias Á; Lucendo AJ;
    United European Gastroenterol J; 2024 Jun; 12(5):585-595. PubMed ID: 38284792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis.
    Straumann A; Lucendo AJ; Miehlke S; Vieth M; Schlag C; Biedermann L; Vaquero CS; Ciriza de Los Rios C; Schmoecker C; Madisch A; Hruz P; Hayat J; von Arnim U; Bredenoord AJ; Schubert S; Mueller R; Greinwald R; Schoepfer A; Attwood S;
    Gastroenterology; 2020 Nov; 159(5):1672-1685.e5. PubMed ID: 32721437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel corticosteroid formulations in the treatment of eosinophilic esophagitis: what is the evidence?
    Walgraeve S; Vanuytsel T
    Acta Gastroenterol Belg; 2023; 86(3):437-448. PubMed ID: 37814560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and Therapeutic Long-term Management of Eosinophilic Esophagitis- Current Concepts and Perspectives for Steroid Use.
    Greuter T; Alexander JA; Straumann A; Katzka DA
    Clin Transl Gastroenterol; 2018 Dec; 9(12):e212. PubMed ID: 30802222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.
    Munoz-Persy M; Lucendo AJ
    Eur J Pediatr; 2018 May; 177(5):649-663. PubMed ID: 29549437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Pharmacologic Therapy for Eosinophilic Esophagitis: A Systematic Review and Network Meta-Analysis.
    Tomizawa Y; Melek J; Komaki Y; Kavitt RT; Sakuraba A
    J Clin Gastroenterol; 2018 Aug; 52(7):596-606. PubMed ID: 28787360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging therapies for eosinophilic esophagitis.
    Greuter T; Hirano I; Dellon ES
    J Allergy Clin Immunol; 2020 Jan; 145(1):38-45. PubMed ID: 31705907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed hypersensitivity reaction to orodispersible budesonide in a case with eosinophilic esophagitis.
    Andrist CM; Jörg L; Greuter T; Gschwend A; Straumann A; Helbling A
    BMC Gastroenterol; 2020 Dec; 20(1):419. PubMed ID: 33308158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent insights on the use of topical steroids in eosinophilic esophagitis.
    Reddy A; Ashat D; Murali AR
    Expert Rev Gastroenterol Hepatol; 2020 Oct; 14(10):953-963. PubMed ID: 32567417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug treatment strategies for eosinophilic esophagitis in adults.
    Lucendo AJ
    Expert Opin Pharmacother; 2022 May; 23(7):827-840. PubMed ID: 35379069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical steroids in eosinophilic esophagitis: Systematic review and meta-analysis of placebo-controlled randomized clinical trials.
    Murali AR; Gupta A; Attar BM; Ravi V; Koduru P
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1111-9. PubMed ID: 26699695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial.
    Lucendo AJ; Miehlke S; Schlag C; Vieth M; von Arnim U; Molina-Infante J; Hartmann D; Bredenoord AJ; Ciriza de Los Rios C; Schubert S; Brückner S; Madisch A; Hayat J; Tack J; Attwood S; Mueller R; Greinwald R; Schoepfer A; Straumann A;
    Gastroenterology; 2019 Jul; 157(1):74-86.e15. PubMed ID: 30922997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Eosinophilic Esophagitis: Dietary and Nondietary Approaches.
    Chen JW
    Nutr Clin Pract; 2020 Oct; 35(5):835-847. PubMed ID: 32822071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Evaluation of Budesonide Orodispersible Tablets for the Treatment of Eosinophilic Esophagitis: A Cost-Utility Analysis.
    Beauchemin C; Castonguay A; Chan ES; Dellon ES; Feagan BG; Ma C; Waserman S; Cook J; Claveau D
    Adv Ther; 2021 Dec; 38(12):5737-5751. PubMed ID: 34699003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic and Clinical Effects of Different Topical Corticosteroids for Eosinophilic Esophagitis: Lessons from an Updated Meta-Analysis of Placebo-Controlled Randomized Trials.
    de Heer J; Miehlke S; Rösch T; Morgner A; Werner Y; Ehlken H; Becher H; Aigner A
    Digestion; 2021; 102(3):377-385. PubMed ID: 32610332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Budesonide Oral Suspension Significantly Improves Eosinophilic Esophagitis Histology Scoring System Results: Analyses From a 12-Week, Phase 2, Randomized, Placebo-controlled Trial.
    Collins MH; Dellon ES; Katzka DA; Hirano I; Williams J; Lan L
    Am J Surg Pathol; 2019 Nov; 43(11):1501-1509. PubMed ID: 31498177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.